- Home
- ARCT vs UFCS Comparison
ARCT vs UFCS Comparison
Compare ARCT & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- UFCS
- Stock Information
- Founded
- ARCT 2013
- UFCS 1946
- Country
- ARCT United States
- UFCS United States
- Employees
- ARCT N/A
- UFCS N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- UFCS Property-Casualty Insurers
- Sector
- ARCT Health Care
- UFCS Finance
- Exchange
- ARCT Nasdaq
- UFCS Nasdaq
- Market Cap
- ARCT 487.0M
- UFCS 642.7M
- IPO Year
- ARCT N/A
- UFCS N/A
- Fundamental
- Price
- ARCT $16.76
- UFCS $26.50
- Analyst Decision
- ARCT Strong Buy
- UFCS Hold
- Analyst Count
- ARCT 7
- UFCS 1
- Target Price
- ARCT $65.00
- UFCS $26.00
- AVG Volume (30 Days)
- ARCT 426.2K
- UFCS 144.6K
- Earning Date
- ARCT 03-06-2025
- UFCS 02-11-2025
- Dividend Yield
- ARCT N/A
- UFCS 2.42%
- EPS Growth
- ARCT N/A
- UFCS N/A
- EPS
- ARCT N/A
- UFCS 1.94
- Revenue
- ARCT $160,399,000.00
- UFCS $1,207,451,000.00
- Revenue This Year
- ARCT $7.33
- UFCS N/A
- Revenue Next Year
- ARCT $4.71
- UFCS $11.31
- P/E Ratio
- ARCT N/A
- UFCS $13.33
- Revenue Growth
- ARCT N/A
- UFCS 10.95
- 52 Week Low
- ARCT $14.30
- UFCS $18.04
- 52 Week High
- ARCT $45.00
- UFCS $31.70
- Technical
- Relative Strength Index (RSI)
- ARCT 45.88
- UFCS 38.63
- Support Level
- ARCT $16.17
- UFCS $25.20
- Resistance Level
- ARCT $21.26
- UFCS $29.01
- Average True Range (ATR)
- ARCT 1.37
- UFCS 0.68
- MACD
- ARCT -0.00
- UFCS -0.40
- Stochastic Oscillator
- ARCT 14.77
- UFCS 32.18
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.